As cofounder and CEO of Revalia Bio, Greg Tietjen revives donated, transplantable human organs and tissues,transforming them into powerful tools for biomedical research. By integrating medicine, engineering and data science, his team uses these living organs as a foundation to accelerate new drug development while lowering costs.
As cofounder and CEO of Revalia Bio, Greg Tietjen revives donated, transplantable human organs and tissues,transforming them into powerful tools for biomedical research. By integrating medicine, engineering and data science, his team uses these living organs as a foundation to accelerate new drug development while lowering costs.